RECRUITING

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Description

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

Conditions

Lymphedema of the Head and Neck
Talk to us

Related Conditions:

Lymphedema of the Head and Neck

Study Overview

On this page

Study Details

Study overview

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

Promoting Self-Management in Head and Neck Cancer Survivors With Lymphedema and Fibrosis [PROMISE Trial]

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Condition
Lymphedema of the Head and Neck
Intervention / Treatment

-

Contacts and Locations

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Nashville

Barbara Murphy, Nashville, Tennessee, United States, 37232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \>18 years of age
  • * Post HNC primary treatment
  • * No evidence of cancer (NED)
  • * Completion of initial lymphedema therapy for head and neck lymphedema
  • * Unable to obtain lymphedema therapy due to barriers noted above
  • * History of lymphedema on the face and neck, with or without fibrosis
  • * Ability to understand English in order to complete questionnaires
  • * Ability to perform self-care activities for LEF management
  • * Ability to provide informed consent
  • * Having an electronic device (a computer, tablet, iPad, or smartphone) and internet access at home
  • * A valid email address
  • * Recurrent or metastatic cancer
  • * Any other active cancer
  • * Acute infection
  • * Acute congestive heart failure
  • * Acute renal failure
  • * Cardiac or pulmonary edema
  • * Sensitive carotid sinus
  • * Severe carotid blockage
  • * Uncontrolled hypertension
  • * Venous thrombosis
  • * Pregnant people
  • * Incarcerated patients

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Abramson Cancer Center at Penn Medicine,

Study Record Dates

2026-08-31